NIH PAR · NEI · R34
PAR-25-358: NEI Clinical Research Study Planning Grant Program (R34 Clinical Trial Not Allowed)
Reviewed by Dr. Meng ZhaoLast reviewed October 16, 2026Data refreshed October 16, 2026Editorial standards
The NEI supports large-scale clinical vision research projects, including randomized clinical trials and epidemiologic studies on eye/vision conditions. At the time of submission, applications requesting support for these activities are expected to provide detailed information regarding the study rationale, design, analytic methods, protocols and procedures, facilities and environment, organizational structure, and collaborative arrangements. This information is best conveyed in a study protocol and Manual of Procedures (MOP), the development of which represents a costly and time-consuming activity. This clinical research planning grant funding opportunity supports applicants in their…
- NOFO number
- PAR-25-358
- Type
- PAR
- Activity code
- R34
- Primary institute
- NEI · National Eye Institute
- Clinical trials
- Not Allowed
- Posted
- Jan 10, 2025
- Opens
- Jan 16, 2025
- Expires
- Jan 8, 2028
PAR-25-358 due dates
4 application due dates remain before the NOFO expires. Dates marked * are NIH standard due dates. Check the related notices below for changes NIH made after posting.
| Application Due Date(s) | Renewal / Resubmission / Revision (as allowed) | AIDS - New/Renewal/Resubmission/Revision, as allowed | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
|---|---|---|---|---|---|
| February 16, 2025 | March 16, 2025 * | May 07, 2025 * | July 2025 | October 2025 | December 2025 |
| June 16, 2025 | July 16, 2025 * | September 07, 2025 * | November 2025 | January 2026 | April 2026 |
| October 16, 2025 | November 16, 2025 * | January 07, 2026 * | March 2026 | May 2026 | July 2026 |
| February 16, 2026 | March 16, 2026 * | May 07, 2026 * | July 2026 | October 2026 | December 2026 |
| June 16, 2026 | July 16, 2026 * | Not Applicable | November 2026 | January 2027 | April 2027 |
| October 16, 2026 | November 16, 2026 * | Not Applicable | March 2027 | May 2027 | July 2027 |
| February 16, 2027 | March 16, 2027 * | Not Applicable | July 2027 | October 2027 | December 2027 |
| June 16, 2027 | July 16, 2027 * | Not Applicable | November 2027 | January 2028 | April 2028 |
| October 16, 2027 | November 16, 2027 * | Not Applicable | March 2028 | May 2028 | July 2028 |
Projects funded under PAR-25-358
NIH RePORTER lists 4 projects funded under PAR-25-358 in FY2022–FY2026, with $2.0M in award dollars. Counts include each project's later non-competing years, which keep the original NOFO number.
Projects funded
4
Distinct projects, FY2022–FY2026
New awards
4
Type 1 (new project) award records
NIH funding
$2.0M
Award dollars under PAR-25-358, FY2022–FY2026
Funding by fiscal year
| Fiscal year | Award records | New awards | Funding |
|---|---|---|---|
| FY2022 | 0 | 0 | $0 |
| FY2023 | 0 | 0 | $0 |
| FY2024 | 0 | 0 | $0 |
| FY2025 | 0 | 0 | $0 |
| FY2026 | 4 | 4 | $2.0M |
Institutions with the most funding
- University of California Los Angeles$542K · 1 project
- Boston Children's Hospital$534K · 1 project
- University of California at Davis$483K · 1 project
- University of Miami School of Medicine$479K · 1 project
Funding institutes
- NEI$2.0M · 4
Activity codes funded
- R344 records
Most recent new awards
- Planning a lighting-centered home modification trial to prevent falls in the visually impaired (opens NIH RePORTER)
University of Miami School of Medicine · 1R34EY038267-01A1 · NEI · Notice Sep 19, 2026
$479KR34
- Deep Learning for low Vision Enhancement (DELVE) (opens NIH RePORTER)
University of California Los Angeles · 1R34EY038270-01A1 · NEI · Notice Sep 10, 2026
$542KR34
- Noninvasive, Trial-Ready Multimodal Imaging Endpoints for Uveitis (opens NIH RePORTER)
University of California at Davis · 1R34EY039557-01 · NEI · Notice Sep 10, 2026
$483KR34
- PEDIATRIC INHERITED RETINAL DISORDERS: TARGETING CRYPTIC SPLICING DEFECTS (opens NIH RePORTER)
Boston Children's Hospital · 1R34EY038248-01 · NEI · Notice Apr 28, 2026
$534KR34
What its predecessor PAR-22-128 funded
PAR-25-358 reissues PAR-22-128. Its funding history is the best guide to who wins under this program: 5 projects and $2.5M in FY2022–FY2026.
Projects funded
5
Distinct projects, FY2022–FY2026
New awards
5
Type 1 (new project) award records
NIH funding
$2.5M
Award dollars under PAR-22-128, FY2022–FY2026
Funding by fiscal year
| Fiscal year | Award records | New awards | Funding |
|---|---|---|---|
| FY2022 | 0 | 0 | $0 |
| FY2023 | 1 | 1 | $313K |
| FY2024 | 4 | 3 | $1.3M |
| FY2025 | 3 | 1 | $967K |
| FY2026 | 0 | 0 | $0 |
Institutions with the most funding
- University of California, San Francisco$983K · 2 projects
- Tufts University Boston$545K · 1 project
- Stanford University$504K · 1 project
- Ohio State University$504K · 1 project
Funding institutes
- NEI$2.5M · 8
Activity codes funded
- R348 records
Most recent new awards
- Decentralized Dry Eye Study, Planning & Feasibility (opens NIH RePORTER)
University of California, San Francisco · 1R34EY037743-01 · NEI · Notice Sep 24, 2025
$492KR34
- Feasibility Studies for the Future Mediterranean Glucose Lowering Dietfor Vision Extension in AMD (M-GLOVE-AMD) (opens NIH RePORTER)
Stanford University · 1R34EY035782-01 · NEI · Notice Aug 28, 2024
$266KR34
- Designing a Pragmatic Registry-based Randomized Controlled Trial for Open-Angle Glaucoma Treatment in the US (opens NIH RePORTER)
University of California, San Francisco · 1R34EY036161-01 · NEI · Notice May 1, 2024
$491KR34
- Identification of School-age Eye conditions Evaluation (ISEE) (opens NIH RePORTER)
Ohio State University · 1R34EY035783-01 · NEI · Notice Feb 21, 2024
$267KR34
- Planning the VICTORY (VIsual ComplicaTions Of PrematuRitY) Study (opens NIH RePORTER)
Tufts University Boston · 1R34EY034969-01 · NEI · Notice May 12, 2023
$313KR34
FY2026 closed on September 30, 2026, but NIH keeps posting that year's awards to RePORTER for several weeks. FY2026 figures reflect records available on October 16, 2026 and may rise slightly at the next refresh.
Participating institutes
2 NIH institutes and offices take applications under PAR-25-358. Contact the program officer at the institute that fits your research before applying.
- NEI · National Eye Institute
- none
Related notices
Jan 28, 2026 · NOT-OD-26-029
NIH Removing AIDS Application Due Dates from NOFOs. See Notice NOT-OD-26-029.
Mar 31, 2025 · NOT-OD-24-084
This funding opportunity was updated to align with agency priorities. Carefully reread the full funding opportunity and make any needed adjustments to your application prior to submission.April 4, 2024 - Overview of Grant Application and Review Changes for Due Dates on or after January 25,…
Aug 31, 2022 · NOT-OD-22-198
Implementation Changes for Genomic Data Sharing Plans Included with Applications Due on or after January 25, 2023. See Notice NOT-OD-22-198.
Aug 5, 2022 · NOT-OD-22-189
Implementation Details for the NIH Data Management and Sharing Policy. See Notice NOT-OD-22-189.
Notices of Special Interest (NOSIs)
NIH has attached 1 NOSI to PAR-25-358; none are active now. A NOSI flags a topic an institute wants to fund through this NOFO.
Award terms
- Application types allowed
- NewResubmission The OER Glossary and the How to Apply Application Guide provide details on these application types. Only those application types listed here are allowed for this NOFO.
- Award budget
- The NEI permits direct costs up to 150,000 per year plus applicable F&A for consortia.
- Project period
- The scope of the proposed project should determine the project period. The maximum period is two years. NIH grants policies as described in the NIH Grants Policy Statement will apply to the applications submitted and awards made from this NOFO.
- Funds available and number of awards
- The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
Summarized from the NOFO text; the full NOFO governs eligibility, budget, and review.
Related NOFOs
- Reissue of PAR-22-128.
Other open NOFOs for R34
- PAR-24-329Development and Testing of Novel Interventions to Improve HIV Prevention, Treatment, and Program Implementation for People Who Use Substances (R34 Clinical Trial Required)NIDA · next due Oct 16, 2026
- PAR-25-284Innovative Pilot Mental Health Services Research Not Involving Clinical Trials (R34 Clinical Trial Not Allowed)NIMH · next due Oct 16, 2026
- PAR-25-032NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)NHLBI · next due Oct 16, 2026
- PAR-25-100Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 Clinical Trial Optional)NIDA · next due Oct 16, 2026
- PAR-25-159Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional)NIAAA · next due Oct 16, 2026
- PAR-25-288Navigator Emergency Department Diversion Models for Non-Urgent Mental Health Concerns (R34 Clinical Trial Required)NIMH · next due Oct 16, 2026
About this page
GotGrant gathers the NOFO, its participation and change notices, and its NOSIs from the NIH Guide for Grants and Contracts, and counts funded projects from NIH RePORTER by the opportunity number each award was made under. Data refreshed October 16, 2026; the NIH Guide is the authoritative source. See our data methodology.